6592:TSEMabuchi Motor Co., Ltd. Analysis
Data as of 2026-03-17 - not real-time
NT$63.80
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Hotai Finance is trading below its long‑term moving average, signaling a bearish backdrop, while the MACD histogram remains positive, hinting at short‑term upward momentum. The RSI sits just above the neutral zone, suggesting modest buying pressure without overextension. Beta is low, which points to limited sensitivity to broader market swings, yet the 30‑day volatility is pronounced, adding a layer of price instability. The company offers a high dividend yield that outpaces many peers, but the payout ratio is elevated, raising questions about long‑run sustainability. Valuation metrics, such as the price‑to‑earnings multiple, are in line with sector averages, and the price‑to‑book ratio hovers near one, indicating a fairly priced stock. However, the balance sheet is heavily leveraged, with a debt‑to‑equity ratio that dwarfs typical industry levels, and return on equity remains modest.
From a fundamentals perspective, revenue growth is tepid and operating margins are thin, limiting the buffer for debt servicing. The cash flow from operations is solid, but free cash flow is negligible, constraining flexibility for dividend payments or debt reduction. Regulatory exposure is typical for a credit services firm, while geographic concentration in Taiwan and China introduces moderate political and economic risk. Overall, the stock presents a mixed picture: attractive yield and fair valuation are offset by high leverage and limited growth, suggesting a cautious stance.
From a fundamentals perspective, revenue growth is tepid and operating margins are thin, limiting the buffer for debt servicing. The cash flow from operations is solid, but free cash flow is negligible, constraining flexibility for dividend payments or debt reduction. Regulatory exposure is typical for a credit services firm, while geographic concentration in Taiwan and China introduces moderate political and economic risk. Overall, the stock presents a mixed picture: attractive yield and fair valuation are offset by high leverage and limited growth, suggesting a cautious stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish long‑term trend versus short‑term MACD support
- Attractive dividend yield but high payout ratio
- Low beta limiting market‑wide downside
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- High leverage constraining financial flexibility
- Modest earnings growth and thin margins
- Valuation in line with peers offering limited upside
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Debt overhang and weak profitability
- Sustaining dividend at current payout unlikely
- Limited growth prospects in a competitive credit market
Key Metrics & Analysis
Financial Health
Revenue Growth102.40%
Profit Margin14.25%
P/E Ratio16.4
ROE8.08%
ROA1.04%
Debt/Equity642.35
P/B Ratio1.1
Op. Cash FlowNT$6.9B
Industry P/E16.5
Technical Analysis
TrendBearish
RSI60.0
SupportNT$56.70
ResistanceNT$65.50
MA 20NT$60.68
MA 50NT$60.80
MA 200NT$65.17
MACDBullish
VolumeStable
Fear & Greed Index79.45
Valuation
Target PriceNT$70.00
Upside/Downside9.72%
GradeFair
TypeValue
Dividend Yield4.62%
Risk Assessment
Beta0.57
Volatility31.34%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.